The aim of this study was to evaluate vaccine efficacy of a commercial vaccine STARTVAC® aimed at reducing intramammary infections (IMI) with Staphylococcus aureus and coagulase-negative staphylococci under field conditions.
The utilization of vaccine in combination with
other infection-control procedures, such as excellent
milking procedures, treatment, segregation, and culling
of known infected cattle, will result in an important
reduction in incidence and duration of intramammary
This website uses its own cookies and those of third parties to improve our services and navigation. If you continue browsing, we understand that you accept our use of these cookies. For more information,
see our cookies policy.I accept